764 related articles for article (PubMed ID: 24281743)
1. Hemorrhagic transformation after ischemic stroke in animals and humans.
Jickling GC; Liu D; Stamova B; Ander BP; Zhan X; Lu A; Sharp FR
J Cereb Blood Flow Metab; 2014 Feb; 34(2):185-99. PubMed ID: 24281743
[TBL] [Abstract][Full Text] [Related]
2. Potential molecular targets of peroxynitrite in mediating blood-brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment.
Chen H; Chen X; Luo Y; Shen J
Free Radic Res; 2018 Dec; 52(11-12):1220-1239. PubMed ID: 30468092
[TBL] [Abstract][Full Text] [Related]
3. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
[TBL] [Abstract][Full Text] [Related]
4. GAS6/Axl Signaling Modulates Blood-Brain Barrier Function Following Intravenous Thrombolysis in Acute Ischemic Stroke.
Guo ZN; Liu J; Chang J; Zhang P; Jin H; Sun X; Yang Y
Front Immunol; 2021; 12():742359. PubMed ID: 34733281
[TBL] [Abstract][Full Text] [Related]
5. Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
Jha R; Battey TW; Pham L; Lorenzano S; Furie KL; Sheth KN; Kimberly WT
Stroke; 2014 Apr; 45(4):1040-5. PubMed ID: 24619394
[TBL] [Abstract][Full Text] [Related]
6. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.
Li Y; Zhong W; Jiang Z; Tang X
Brain Res Bull; 2019 Jan; 144():46-57. PubMed ID: 30448453
[TBL] [Abstract][Full Text] [Related]
7. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation.
Ho WM; Reis C; Akyol O; Akyol GY; Applegate R; Stier G; Martin R; Zhang JH
Curr Drug Targets; 2017; 18(12):1441-1459. PubMed ID: 27538508
[TBL] [Abstract][Full Text] [Related]
9. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.
Lapchak PA
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):38-43. PubMed ID: 11898581
[TBL] [Abstract][Full Text] [Related]
11. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
[TBL] [Abstract][Full Text] [Related]
12. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.
Rosell A; Cuadrado E; Ortega-Aznar A; Hernández-Guillamon M; Lo EH; Montaner J
Stroke; 2008 Apr; 39(4):1121-6. PubMed ID: 18323498
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
Wang W; Li M; Chen Q; Wang J
Mol Neurobiol; 2015 Dec; 52(3):1572-1579. PubMed ID: 25367883
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1/TLR4/NF-κB mediated neutrophil infiltration in thromboembolic stroke rats.
Kong L; Ma Y; Wang Z; Liu N; Ma G; Liu C; Shi R; Du G
Int Immunopharmacol; 2021 May; 94():107507. PubMed ID: 33657523
[TBL] [Abstract][Full Text] [Related]
16. [VEGF-A therapeutic target against hemorrhagic transformation after t-PA treatment].
Kanazawa M; Takahashi T; Kawamura K; Shimohata T
Rinsho Shinkeigaku; 2019 Nov; 59(11):699-706. PubMed ID: 31656268
[TBL] [Abstract][Full Text] [Related]
17. Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.
Liu C; Xie J; Sun S; Li H; Li T; Jiang C; Chen X; Wang J; Le A; Wang J; Li Z; Wang J; Wang W
Cell Mol Neurobiol; 2022 Apr; 42(3):621-646. PubMed ID: 33125600
[TBL] [Abstract][Full Text] [Related]
18. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
19. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
20. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Singh S; Houng AK; Reed GL
Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
